These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

448 related items for PubMed ID: 10915418

  • 21. Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment.
    Bayas A, Gold R.
    J Neurol; 2003 Dec; 250 Suppl 4():IV3-8. PubMed ID: 14712395
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Interferon beta 1a.
    Pozzilli C, Koudriavtseva T.
    Baillieres Clin Neurol; 1997 Oct; 6(3):481-93. PubMed ID: 10101585
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode.
    Goodin DS, Bates D.
    Mult Scler; 2009 Oct; 15(10):1175-82. PubMed ID: 19737851
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. [Current status of interferon beta-1b in multiple sclerosis therapy].
    Hartung HP.
    Med Klin (Munich); 2001 Sep 15; 96 Suppl 1():11-6. PubMed ID: 11603110
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Interferon-beta treatment in patients with childhood-onset multiple sclerosis.
    Mikaeloff Y, Moreau T, Debouverie M, Pelletier J, Lebrun C, Gout O, Pedespan JM, Van Hulle C, Vermersch P, Ponsot G.
    J Pediatr; 2001 Sep 15; 139(3):443-6. PubMed ID: 11562627
    [Abstract] [Full Text] [Related]

  • 35. [Multiple sclerosis: therapy with recombinant beta-1b interferon: initial results with 30 multiple sclerosis patients in northwest Switzerland].
    Huber S, Spycher M, Lechner-Scott J, Bellaiche Y, Steck AJ, Kappos L.
    Schweiz Med Wochenschr; 1996 Aug 31; 126(35):1475-81. PubMed ID: 8927950
    [Abstract] [Full Text] [Related]

  • 36. [Interferon-beta 1B in the treatment of remittent-recurrent multiple sclerosis. Clinical experience of the Valencia group. Multiple sclerosis study group of the city of Valencia].
    Rev Neurol; 1997 Dec 31; 25(148):1876-9. PubMed ID: 9528021
    [Abstract] [Full Text] [Related]

  • 37. Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study.
    Schwid SR, Thorpe J, Sharief M, Sandberg-Wollheim M, Rammohan K, Wendt J, Panitch H, Goodin D, Li D, Chang P, Francis G, EVIDENCE (Evidence of Interferon Dose-Response: European North American Comparative Efficacy) Study Group, University of British Columbia MS/MRI Research Group.
    Arch Neurol; 2005 May 31; 62(5):785-92. PubMed ID: 15883267
    [Abstract] [Full Text] [Related]

  • 38. [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].
    Ouallet JC.
    Rev Neurol (Paris); 2010 Jan 31; 166(1):21-31. PubMed ID: 19596382
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.